# Bristol-Myers Squibb (BMY) total assets: $90.04B in 2025

URL: https://funkfolio.com/stock/BMY/total-assets

> Bristol-Myers Squibb (BMY) total assets were $90.04B at the end of fiscal 2025, down 2.8% from fiscal 2024. Over five fiscal years it shrank 5.3% a year.

---

## Bristol-Myers Squibb (BMY) total assets

**Total assets · fiscal 2025:** $90.04B at Dec 31, 2025

Bristol-Myers Squibb (BMY) had total assets of $90.04B at the end of fiscal 2025 (December 31, 2025). That is 2.8% lower than the $92.60B of fiscal 2024. Figures as of 18 Nov 2026, 09:36 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Total assets, fiscal 2025:** $90.04B
- **Change on fiscal 2024:** −2.8%
- **Growth, 5 years:** −5.3% a year
- **Growth, 10 years:** +11.0% a year
- **Highest on record:** $129.94B fiscal 2019
- **Lowest on record:** $29.49B fiscal 2008
- **Fiscal years on record:** 18 2008–2025

Figures as of 18 Nov 2026, 09:36 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Bristol-Myers Squibb total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 5.3% a year; over ten years the rate was 11.0% a year. Across the 18 fiscal years on record (2008–2025), the highest was $129.94B in fiscal 2019 and the lowest $29.49B in fiscal 2008.

### Total assets by fiscal year

### Bristol-Myers Squibb total assets, year by year

Bristol-Myers Squibb (BMY) total assets by fiscal year

| Fiscal year | Total assets | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $90.04B | 2.8% down | Dec 31, 2025 |
| 2024 | $92.60B | 2.7% down | Dec 31, 2024 |
| 2023 | $95.16B | 1.7% down | Dec 31, 2023 |
| 2022 | $96.82B | 11.4% down | Dec 31, 2022 |
| 2021 | $109.31B | 7.7% down | Dec 31, 2021 |
| 2020 | $118.48B | 8.8% down | Dec 31, 2020 |
| 2019 | $129.94B | 271.4% up | Dec 31, 2019 |
| 2018 | $34.99B | 4.3% up | Dec 31, 2018 |
| 2017 | $33.55B | 0.5% down | Dec 31, 2017 |
| 2016 | $33.71B | 6.2% up | Dec 31, 2016 |
| 2015 | $31.75B | 5.9% down | Dec 31, 2015 |
| 2014 | $33.75B | 12.5% down | Dec 31, 2014 |
| 2013 | $38.59B | 7.5% up | Dec 31, 2013 |
| 2012 | $35.90B | 8.9% up | Dec 31, 2012 |
| 2011 | $32.97B | 6.1% up | Dec 31, 2011 |
| 2010 | $31.08B | 0.2% up | Dec 31, 2010 |
| 2009 | $31.01B | 5.2% up | Dec 31, 2009 |
| 2008 | $29.49B | — | Dec 31, 2008 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

### How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

### Total assets at health care companies of similar size

Total assets of Bristol-Myers Squibb and comparable companies

| Company | Total assets | Fiscal year |
| --- | --- | --- |
| [Vertex Pharmaceuticals VRTX](https://funkfolio.com/stock/VRTX/total-assets) | $25.64B | 2025 |
| [Medtronic MDT](https://funkfolio.com/stock/MDT/total-assets) | $93.03B | 2026 |
| Bristol-Myers Squibb BMY | $90.04B | 2025 |
| [Stryker SYK](https://funkfolio.com/stock/SYK/total-assets) | $47.84B | 2025 |
| [McKesson MCK](https://funkfolio.com/stock/MCK/total-assets) | $82.32B | 2026 |
| [Sanofi SNY](https://funkfolio.com/stock/SNY/total-assets) | €126.81B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Bristol-Myers Squibb, figure by figure

- [Bristol-Myers Squibb market cap](https://funkfolio.com/stock/BMY/market-cap)
- [Bristol-Myers Squibb revenue](https://funkfolio.com/stock/BMY/revenue)
- [Bristol-Myers Squibb earnings](https://funkfolio.com/stock/BMY/earnings)
- [Bristol-Myers Squibb earnings per share (EPS)](https://funkfolio.com/stock/BMY/eps)
- [Bristol-Myers Squibb P/E ratio](https://funkfolio.com/stock/BMY/pe-ratio)
- [Bristol-Myers Squibb P/S ratio](https://funkfolio.com/stock/BMY/ps-ratio)
- [Bristol-Myers Squibb P/B ratio](https://funkfolio.com/stock/BMY/pb-ratio)
- [Bristol-Myers Squibb free cash flow](https://funkfolio.com/stock/BMY/free-cash-flow)
- [Bristol-Myers Squibb operating margin](https://funkfolio.com/stock/BMY/operating-margin)
- [Bristol-Myers Squibb dividend](https://funkfolio.com/stock/BMY/dividend)
- [Bristol-Myers Squibb shares outstanding](https://funkfolio.com/stock/BMY/shares-outstanding)
- [Bristol-Myers Squibb total debt](https://funkfolio.com/stock/BMY/total-debt)
- [Bristol-Myers Squibb cash on hand](https://funkfolio.com/stock/BMY/cash)
- [Bristol-Myers Squibb return on equity (ROE)](https://funkfolio.com/stock/BMY/roe)
- [Bristol-Myers Squibb return on invested capital (ROIC)](https://funkfolio.com/stock/BMY/roic)

[Bristol-Myers Squibb (BMY) overview: price, valuation and scorecard](https://funkfolio.com/stock/BMY) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Bristol-Myers Squibb total assets: questions and answers

**How large are Bristol-Myers Squibb's total assets?**

Bristol-Myers Squibb (BMY) had total assets of $90.04B at the end of fiscal 2025 (December 31, 2025). That is 2.8% lower than the $92.60B of fiscal 2024.

**What is the growth rate of Bristol-Myers Squibb's total assets?**

Over the five fiscal years to 2025 total assets shrank at a compound 5.3% a year; over ten years the rate was 11.0% a year.

**What are the highest and lowest total assets figures on record for Bristol-Myers Squibb?**

Across the 18 fiscal years on record (2008–2025), the highest was $129.94B in fiscal 2019 and the lowest $29.49B in fiscal 2008.

**How is Bristol-Myers Squibb's total assets calculated?**

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Bristol-Myers Squibb it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: total assets

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.
